Contents:

Corporate Structure Strategy statement Highlights a company’s strengths / weaknesses and its potential for future growth. The strategy analysis gives you an insight into the following: - M&A - Regional strategies - Therapeutic focus - R&D strategy - Licensing activities - Commentary on future prospects, including brokers’ overviews - Interview with a key person (where available), including quotes and opinions - Forecasting table (top 30 companies only), showing events with major potential impact Financial Review Company sales performance as well as analyst’s comments and forecasts. Company Sales Performance: - Financial review - Latest results - Sales by geographical region & leading country - Sales by country and subsidiary - Analysis comments Product Portfolio Company Profiles reviews up to 40 products per company, whilst annual reports from the top 10 pharmaceutical companies cover up to a maximum of 10 drugs. The section shows: - Summary table of products facing patent expiry. - Breakdown by relevant therapy area, within which, each product is discussed under the following headings: general, licensing, patents, clinical data, lifecycle management, competition and analysts’ forecasts/comments. R&D Pipelines Comprehensive details of the projects that the company has in its R&D pipeline including: - Research pipeline summary table. - Introduction to the R&D activities of the company. - Breakdown by relevant therapy area, within which, each project is detailed (up to 2 A4 pages), including information on clinical status and analysts’ forecasts. - Quotes from senior personnel gleaned from conferences may also be included in this section when available. Key figures - Sales by business segment. - Sales by geographical region. Analyst figures IMS sales data - Pharmaceutical sales by geographical region and leading countries. - Top 5 third level therapeutic classes. - Leading international products - Pharmaceutical sales analysis by age Employee data Licensing/Co-Marketing Agreements Displayed in a tabular format to enable you to have “at a glance” review of the licensing activities of the company. Three sections are available to review licensing activities: - Marketed products - R&D pipeline products - General research collaborations, including combinatorial chemistry, proprietary technologies etc. Major Events Summary of the major events that have affected the company. This includes recent and historical events. Two sections - Mergers and Acquisitions - Other major events Events are organised in chronological order. Subsidiaries listing Mini-profile of each subsidiary that the company has worldwide showing address, major contacts and principal products.